Abstract: Sulfur heteroatom substitution at the C4 position of 18F-labeled fatty acids yields a tracer that is retained in proportion to the beta-oxidation rates in mammalian tissue, particularly hypoxic myocardium. Most preferably, the invention is embodied in an [18F]fluoro-4-thia-fatty acid having a chain length of between 8 to 20 carbon atoms. The 18F-labeled 4-thia fatty acids of this invention find particular utility the radiolabelling of tissue sites (e.g., myocardium) for purposes of positron emission tomography.

Abstract: Fatty acid sorbitan esters by direct reaction of sorbitol with fatty acid using a phosphorus oxyacid, including reducing phosphorus oxyacid particulary phosphouous acid, catalyst system and an alkali or alkali earth metal base, particulaly oxide, hydroxide or carbonate, in an axid:base molar ratio of 0.9:1 to 1.7:1, at a calalust concentration of 1.5 to 30%, particularly 3 to 12%, by weight of sorbitol can have lower color than products of prior commercial bulk processes even without the use of activated carbon and product bleaching typically used previously. The esters can be further reacted with alkylene oxide to make desivatives, particularly polysorbates. The esters and polyalkyleneoxy detivatives are useful surfactants in various application. Products of low color made without using activated carbon or bleaching are attractive for personal care applications.

Abstract: An acylamino acid for enhancing the bio-availability of substances in organisms by permeabilization of cell membranes, the acylamino acid having general formula (I) wherein R1 is hydrogen, a primary, secondary or tertiary alkyl or alkenyl group and R2 is hydrogen, a straight or branched chain alkyl group or a straight or branched chain substituted alkyl group, the substituted being selected from thio, thioether, hydroxy, carboxy, quarternary ammonium, amide, heterocyclic, benzyl, substituted benzyl, amino, substituted amino groups and difunctional alkyl groups linking to the nitrogen atom. A preferred acylamino acid for incorporating into an animal or fish feed is 2-palmitoylaminoproprionic acid.

Abstract: The present invention includes 16-HETE analogs which are agonists and antagonists of 16-HETE. The compositions may be formulated in pharmaceutically acceptable formulations. The invention also includes methods and products for inhibiting neutrophil adhesion and neutrophil aggregation using the 16-HETE agonists. One method of the invention involves the administration of a 16-HETE agonist in combination with a thrombolytic agent to a patient suffering from thromboembolic stroke.

Abstract: A process for the transesterification of fat and/or oil of biological origin by means of alcoholysis comprises the following steps: provision in a vessel of fat and/or oil of biological origin to be transesterified, and implementation of alcoholysis by addition of an alkanol, in particular of a monohydric alkanol, and of a catalyst to the fat and/or oil that has been provided. with a view to eliminating the disadvantages of traditional transesterification processes, a metal salt of an amino acid or of an amino-acid derivative is used as catalyst, said metal salt being insoluble in alkanols.

Abstract: The present invention provides a process for the production of an ester, including reacting an alcohol with a carbonyl-like compound in the presence of a first esterification catalyst; and adding a second esterification catalyst to the reaction mixture at some time after initiation of the esterification reaction. The staged addition of the esterification catalyst according to the present invention provides a reduced reaction time to achieve a targeted conversion to esters.

Abstract: The invention relates to a pharmaceutically acceptable prodrug which is a covalent conjugate of a pharmacologically active compound and an intracellular transporting adjuvant, characterized by the presence of a covalent bond which is scission-sensitive to intracellular enzyme activity. The prodrug may be used in a technique for treating a condition or disease in a mammal related to supranormal intracellular enzyme activity, whereby on administering it to a human having such condition or disease, the bond is broken in response to such activity, and the pharmacologically active compound is activated selectively within cells having such supranormal intracellular enzyme activity.

Abstract: This invention uses acetone/water mixtures at various concnetration and temperatures as a cost effective method for recoveing soy saponins of high purity from soybean-derived materials, while also affording an economical means of recovering soy isoflavones as a by-product.

Abstract: The present invention provides therapeutic conjugates which comprise a therapeutic compound bound to one to three acyl groups derived from fatty acids. The therapeutic compounds are preferably non-steroidal anti-infiammatory agents which include a carboxylic acid group. The compounds involve the use of tromethamine or ethanolamine derivative to link the acyl groups derived from fatty acids to the therapeutic compounds.

Abstract: The invention relates to a method for obtaining fatty acid esters and fatty acids, preferably unsaturated fatty acid ethyl esters, from biological sources by continuous, combined in-situ extraction, reaction and chromatography. The invention is characterized in that simultaneously and in the same location, in the presence of a compressed gas and an 0.5-5 % stream of lower alcohols as modifiers and in the presence of an inert catalyst, the fatty acids are fully transesterified from their native fatty acid sources, which are selectively desorbed and eluated in the conditions specified above.

Abstract: A compound of formula (1), and compositions containing a plurality of such compounds, wherein, independently at each occurrence, R1 is a linear alkyl group having at least twenty carbons; R2 is selected from the diradical that results when two carboxyl groups are removed from polymerized fatty acid, and a linear C4-12 hydrocarbon group, with the proviso that at least one occurrence of R2 is the diradical that results when two carboxyl groups are removed from polymerized fatty acid; R3 is a diradical selected from C2-36 hydrocarbons and C4-30 poly(alkyleneoxides); X is selected from O and NH such that X—R3—X is selected from O—R3—O and NH—R3—O; and n represents a number of repeating units selected from 1-5, may be used as a vehicle for hot melt printing inks, including inks for ink jet printing.

Abstract: A method for obtaining an oil that is rich in hydroxyoctadecadienoic(HODE) fatty acids or the esters thereof. According to the inventive method, controlled oxidation of the linoleic acid and/or the linolenic acid or the esters thereof is performed in the presence of an oxidation catalyst. The oxidation is terminated when the HODE content or total ester content is more than 5 % and/or the 9-hydroxy-10,12-octadecadienoic(9-HODE) acid isomer or ester content is more than 1.5 % and reduction occurs for the hydroperoxides formed during the oxidation reaction by a reducer. The invention can be used as a medicament, food supplement or cosmetic.

Abstract: 15-HETE derivatives with enhanced metabolic stability and methods of their use for treating dry eye are disclosed.

Abstract: The invention relates to plant seeds that contain an oil having an oleic acid content of more than 5% and less than 65% by weight based upon the total fatty acid content, a linoleic acid content of more than 1% and less than 65% by weight based upon the total fatty acid content, a palmitic acid content of more than 20% and less than 40% by weight based upon the total fatty acid content, a stearic acid content of more than 3% and less than 15% based upon the total fatty acid content, and wherein the palmitoleic acid content is less than 4% based upon the total fatty acid content, and the asclepic acid content is less than 4% based upon the total fatty acid content. The invention further relates to the oil that can be obtained from the seeds, the use of that oil and to plants grown from the seeds or producing the seeds.

Abstract: Lipid compositions enriched in unsaturated fatty acid-containing triacylglycerols are made from chicken fat. The method involves solvent fractionation of chicken fat to provide a lipid composition containing enriched monounsaturated fatty acid esters (MUFAs) and polyunsaturated fatty acid esters (PUFAs).

Abstract: The invention relates to the process of extraction of volatile oils from plant material, such as turmeric (Curcuma spp.), comprising: subjecting freshly collected plant material to mechanical working, boiling the worked plant material, collecting the distillate and separating the components.

Abstract: A process for the extraction and concentration of unsaponifiable substances, containing liposoluble vitamins and provitamins, growth factors and animal and vegetable hormones, from residues of the industrialization of animal or vegetable products. This process does not require the use of solvents. Its main goal is to obtain the separation of these “valuable products”, by means of distillation/evaporation at high vacuum, and the production of fatty acids and other high quality organic acids, once the recovery of the unsaponifiable fraction of residues from the industrialization of animal or vegetable products, is of great commercial interest.

Abstract: A synthesis process is disclosed for producing a conjugated fatty acid at specified temperature in high yield, including providing an ester of a fatty acid having somewhere in its carbon chain a chain of four carbon atoms such that carbon one bears one hydrogen and one hydroxyl group, carbon two bears two hydrogen atoms, and a double bond is positioned between carbon three and carbon four and reacting with a chloride selected from the group consisting of toluenesulfonyl chloride, methanesulfonyl chloride, benzenesulfonyl chloride, alkylsulfonyl chloride, and arylsulfonyl chloride at a temperature in the range of 10° C.-100° C., preferably 20° C.-50° C. The synthesis process provides a conjugated fatty acid formed from the ester reacted with diazabicycloundecene. In one aspect, the ester is formed in a pyridine solvent. In one aspect, a mesylate is formed with mesyl chloride in acetonitrile and triethyl amine.

Abstract: A phenyl carboxylate is produced by allowing benzene, a carboxylic acid and molecular oxygen to react with each other in the coexistence of a palladium catalyst with at least one additive selected from alcohols, aldehydes, cyclic hydrocarbons and formic acid. By using the additive, the reduction of catalytic activity of the palladium catalyst with time is minimized.

Abstract: This invention provides a process for producing a 5-hydroxy-3-oxopentanoic acid, a useful pharmaceutical intermediate, easily from a readily available, inexpensive starting material without using any extraordinary production equipment such as a very-low-temperature reactor. Thus, this invention provides a process for producing a 5-hydroxy-3-oxopentanoic acid which comprises permitting a lithium amide to act upon a mixture of an acetic acid ester and a 3-hydroxypropionic acid derivative at not below −20° C. Further, this invention also provides a process for producing a 5-hydroxy-3-oxopentanoic acid which comprises treating a mixture of an acetic acid ester and a 3-hydroxypropionic acid derivative with a Grignard reagent to prepare a mixture of a compound and an acetic acid ester of the above formula (I), and permitting a lithium amide to act upon the mixture at a temperature not below −20° C.